Earlier this month, the South Korean biosimilar maker secured approval for three other drugs from Europe: Eydenzelt, referencing blockbuster eye disease treatment Eylea; Stoboclo and Osenvelt.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Regeneron paid credit card fees to distributors on the condition that distributors did not ...

As a result, the DOJ alleges that the ASP of Regeneron's Eylea drug was inflated, which inappropriately increased Medicare reimbursements. By reimbursing credit card fees, Regeneron subsidized the ...

Regeneron paid credit card fees to distributors on the condition that those distributors did not charge purchasers of its Eylea drug more to use a credit card. The Company's payments subsidized ...

Eylea customers more to use a credit card; (2) these payments subsidized the prices that customers paid when using credit cards to purchase Eylea; (3) as a result, Regeneron offered a price ...

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Regeneron paid credit card fees to distributors on the condition that distributors did not ...

Eylea customers more to use a credit card; (2) these payments subsidized the prices that customers paid when using credit cards to purchase Eylea; (3) as a result, Regeneron offered a price ...

Imagine being able to generate and customize diagrams, like pie charts, with just a few simple prompts—no extra software, no steep learning curve. This new feature, still in its beta phase ...

Regeneron paid credit card fees to distributors on the condition that those distributors did not charge purchasers of its Eylea drug more to use a credit card. The Company's payments subsidized ...

The treatment is a biosimilar that could compete with Regeneron Pharmaceuticals’ Eylea. Teva and Alvotech have been working together in a strategic partnership since 2020. Teva Pharmaceutical ...

The trial, designed to compare the efficacy, safety, and immunogenicity of AVT06 with Eylea, reached the main goal, according to its topline data from January 2024. The duo said the FDA process to ...

Regeneron paid credit card fees to distributors on the condition that those distributors did not charge purchasers of its Eylea drug more to use a credit card. The Company's payments subsidized the ...